| DAA2026 |
Mutations in mitochondrial DNA accumulate |
Physiological |
heart, kidney, skeletal muscle, cerebral cortex, cerebellum |
Human |
— |
— |
|
| DAA623 |
Other forms of chronic ischemic heart disease |
Pathological |
heart |
Human |
— |
SeriesMorbidity |
|
| DAA2598 |
Renewal rate of cardiomyocytes decreases with age |
Physiological |
heart |
Human |
— |
— |
|
| DAA708 |
Response to beta-adrenergic stimulation decreased |
Physiological |
heart |
Human |
— |
— |
|
| DAA1969 |
Alox5 arachidonate 5-lipoxygenase (5-LOX) mRNA expression decrease |
Molecular |
heart |
Mouse |
Alox5 |
— |
|
| DAA1965 |
Alox5 arachidonate 5-lipoxygenase (5-LOX) mRNA expression increase |
Molecular |
heart |
Mouse |
Alox5 |
— |
|
| DAA1963 |
Alox5 arachidonate 5-lipoxygenase (5-LOX) promoter methylation increase |
Molecular |
heart |
Mouse |
Alox5 |
— |
|
| DAA1968 |
Dnmt3a mRNA expression decrease |
Molecular |
heart |
Mouse |
Dnmt3a |
— |
|
| DAA1293 |
eukaryotic translation initiation factor 2a |
Molecular |
heart |
Mouse |
Eif2a |
8.0% Decrease Gene Expression Level |
|
| DAA1294 |
fibronectin 1 |
Molecular |
heart |
Mouse |
Fn1 |
8.0% Increase Gene Expression Level |
|
| DAA1295 |
growth arrest and DNA-damage-inducible 45 alpha |
Molecular |
heart |
Mouse |
Gadd45a |
5.0% Decrease Gene Expression Level |
|
| DAA1297 |
neural precursor cell expressed, developmentally down-regulated gene 8 |
Molecular |
heart |
Mouse |
Nedd8 |
3.0% Decrease Gene Expression Level |
|
| DAA1292 |
NYN domain and retroviral integrase containing |
Molecular |
heart |
Mouse |
Nynrin |
8.0% Increase Gene Expression Level |
|
| DAA704 |
Cellular hypertrophy in left ventricular wall |
Physiological |
left ventricle |
Human |
— |
— |
|
| DAA703 |
Wall increases in thickness |
Physiological |
left ventricle |
Human |
— |
— |
|